Emergency presentations in patients treated with immune checkpoint inhibitors
Affiliation
The Christie NHS Trust, Wilmslow Road, Manchester, M20 4BXIssue Date
2020
Metadata
Show full item recordCitation
Copson E, Coles C, Kirwan C, McIntosh S, Palmieri C, Rea D. The breast cancer trainees research collaborative group. Breast Cancer Research and Treatment. 2020;180:595-Journal
European Journal of CancerDOI
10.1016/j.ejca.2020.02.025PubMed ID
32224417Additional Links
https://dx.doi.org/10.1016/j.ejca.2020.02.025Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.ejca.2020.02.025
Scopus Count
Collections
Related articles
- Emergency Presentations of Immune Checkpoint Inhibitor-Related Endocrinopathies.
- Authors: Knight T, Cooksley T
- Issue date: 2021 Aug
- Patient and treatment characteristics of emergency presentations due to immune-mediated toxicities.
- Authors: Nahm SH, Heywood R, Callaghan S, Serra-Bellver P, Gupta A, Cooksley T, Lorigan P
- Issue date: 2022 Mar
- Emergency management of immune-related toxicity.
- Authors: Cooksley T, Stutman R, Klotz A
- Issue date: 2020 Jul
- Management of Immune Checkpoint Inhibitor Toxicities: A Review and Clinical Guideline for Emergency Physicians.
- Authors: Hryniewicki AT, Wang C, Shatsky RA, Coyne CJ
- Issue date: 2018 Oct
- Immune checkpoint blockade toxicity among patients with cancer presenting to the emergency department.
- Authors: Peyrony O, Tieghem Y, Franchitti J, Ellouze S, Morra I, Madelaine-Chambrin I, Flicoteaux R, Baroudjian B, Azoulay E, Chevret S, Fontaine JP
- Issue date: 2019 May